CYTH - Cyclo Therapeutics, Inc.
0.7206
0.010 1.374%
Share volume: 188,267
Last Updated: 03-25-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.02%
PREVIOUS CLOSE
CHG
CHG%
$0.71
0.01
0.01%
View ratios
| Fiscal Date | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 12-18-2024 | 05-15-2024 | 08-14-2024 | 11-14-2024 | |
| Total revenue | 517.079 K | 202.450 K | 123.104 K | 233.772 K | |
| Cost of revenue | 44.952 K | 12.196 K | 13.882 K | 17.239 K | |
| Gross profit | 474.714 K | 190.627 K | 109.723 K | 216.974 K | |
| -59.84% | -42.44% | 97.75% | |||
| Operating expenses | 664.849 K | 4.368 M | 4.708 M | 7.546 M | |
| Selling general and admin | -1.687 M | 1.523 M | 1.216 M | 2.053 M | |
| Research and development | 2.352 M | 2.845 M | 3.492 M | 5.493 M | |
| Total expenses | 1.476 M | 5.311 M | 5.745 M | 8.506 M | |
| 259.85% | 8.16% | 48.06% | |||
| Operating income | -1.004 M | -5.121 M | -5.636 M | -8.289 M | |
| Ebit | -900.041 K | -4.343 M | -5.981 M | -8.833 M | |
| Pretax income | -900.041 K | -4.343 M | -5.981 M | -8.833 M | |
| 382.54% | 37.72% | 47.68% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -900.041 K | -4.343 M | -5.981 M | -8.833 M | |
| -382.54% | -37.72% | -47.68% |
